The collaboration between Takeda Pharmaceutical Co. and the MIT School of Engineering has yielded groundbreaking research and discoveries in the use of AI and machine learning in healthcare and drug development. The program has resulted in a patent for a system that improves the manufacturing of small-molecule medicines and has opened up new opportunities for MIT faculty and students.